BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21622647)

  • 1. New mechanism of X-linked anhidrotic ectodermal dysplasia with immunodeficiency: impairment of ubiquitin binding despite normal folding of NEMO protein.
    Hubeau M; Ngadjeua F; Puel A; Israel L; Feinberg J; Chrabieh M; Belani K; Bodemer C; Fabre I; Plebani A; Boisson-Dupuis S; Picard C; Fischer A; Israel A; Abel L; Veron M; Casanova JL; Agou F; Bustamante J
    Blood; 2011 Jul; 118(4):926-35. PubMed ID: 21622647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-sided ubiquitin binding of NF-κB essential modulator (NEMO) zinc finger unveiled by a mutation associated with anhidrotic ectodermal dysplasia with immunodeficiency syndrome.
    Ngadjeua F; Chiaravalli J; Traincard F; Raynal B; Fontan E; Agou F
    J Biol Chem; 2013 Nov; 288(47):33722-33737. PubMed ID: 24100029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.
    Döffinger R; Smahi A; Bessia C; Geissmann F; Feinberg J; Durandy A; Bodemer C; Kenwrick S; Dupuis-Girod S; Blanche S; Wood P; Rabia SH; Headon DJ; Overbeek PA; Le Deist F; Holland SM; Belani K; Kumararatne DS; Fischer A; Shapiro R; Conley ME; Reimund E; Kalhoff H; Abinun M; Munnich A; Israël A; Courtois G; Casanova JL
    Nat Genet; 2001 Mar; 27(3):277-85. PubMed ID: 11242109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.
    Vinolo E; Sebban H; Chaffotte A; Israël A; Courtois G; Véron M; Agou F
    J Biol Chem; 2006 Mar; 281(10):6334-48. PubMed ID: 16379012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.
    Kawai T; Nishikomori R; Izawa K; Murata Y; Tanaka N; Sakai H; Saito M; Yasumi T; Takaoka Y; Nakahata T; Mizukami T; Nunoi H; Kiyohara Y; Yoden A; Murata T; Sasaki S; Ito E; Akutagawa H; Kawai T; Imai C; Okada S; Kobayashi M; Heike T
    Blood; 2012 Jun; 119(23):5458-66. PubMed ID: 22517901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency.
    Kawai T; Nishikomori R; Heike T
    Allergol Int; 2012 Jun; 61(2):207-17. PubMed ID: 22635013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
    Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
    J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO).
    Haverkamp MH; Marciano BE; Frucht DM; Jain A; van de Vosse E; Holland SM
    J Clin Immunol; 2014 May; 34(4):436-43. PubMed ID: 24682681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NF-kappaB signalling pathway in human diseases: from incontinentia pigmenti to ectodermal dysplasias and immune-deficiency syndromes.
    Smahi A; Courtois G; Rabia SH; Döffinger R; Bodemer C; Munnich A; Casanova JL; Israël A
    Hum Mol Genet; 2002 Oct; 11(20):2371-5. PubMed ID: 12351572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
    Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
    J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of NEMO zinc finger and impact of an anhidrotic ectodermal dysplasia with immunodeficiency-related point mutation.
    Cordier F; Vinolo E; Véron M; Delepierre M; Agou F
    J Mol Biol; 2008 Apr; 377(5):1419-32. PubMed ID: 18313693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
    Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel hypomorphic mutation in IKBKG impairs NEMO-ubiquitylation causing ectodermal dysplasia, immunodeficiency, incontinentia pigmenti, and immune thrombocytopenic purpura.
    Ramírez-Alejo N; Alcántara-Montiel JC; Yamazaki-Nakashimada M; Duran-McKinster C; Valenzuela-León P; Rivas-Larrauri F; Cedillo-Barrón L; Hernández-Rivas R; Santos-Argumedo L
    Clin Immunol; 2015 Oct; 160(2):163-71. PubMed ID: 26117626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective nuclear IKKα function in patients with ectodermal dysplasia with immune deficiency.
    Temmerman ST; Ma CA; Zhao Y; Keenan J; Aksentijevich I; Fessler M; Brown MR; Knutsen A; Shapiro R; Jain A
    J Clin Invest; 2012 Jan; 122(1):315-26. PubMed ID: 22156202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
    Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
    J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment of A20 by the C-terminal domain of NEMO suppresses NF-κB activation and autoinflammatory disease.
    Zilberman-Rudenko J; Shawver LM; Wessel AW; Luo Y; Pelletier M; Tsai WL; Lee Y; Vonortas S; Cheng L; Ashwell JD; Orange JS; Siegel RM; Hanson EP
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1612-7. PubMed ID: 26802121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
    Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
    Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.
    Hanson EP; Monaco-Shawver L; Solt LA; Madge LA; Banerjee PP; May MJ; Orange JS
    J Allergy Clin Immunol; 2008 Dec; 122(6):1169-1177.e16. PubMed ID: 18851874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB.
    Du M; Ea CK; Fang Y; Chen ZJ
    Mol Cell; 2022 Jul; 82(13):2415-2426.e5. PubMed ID: 35477005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.